MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma.
about
miR-145 mediated the role of aspirin in resisting VSMCs proliferation and anti-inflammation through CD40Role of microRNAs in inflammation-associated liver cancerTargeting MicroRNAs in Cancer Gene Therapy.MicroRNA-340 inhibits invasion and metastasis by downregulating ROCK1 in breast cancer cells.Exportin 1 (XPO1) inhibition leads to restoration of tumor suppressor miR-145 and consequent suppression of pancreatic cancer cell proliferation and migration.miR-145-5p inhibits epithelial-mesenchymal transition via the JNK signaling pathway by targeting MAP3K1 in non-small cell lung cancer cells.Targeting Rho GTPase effector p21 activated kinase 4 (PAK4) suppresses p-Bad-microRNA drug resistance axis leading to inhibition of pancreatic ductal adenocarcinoma proliferation.miR-124 inhibits progression of hepatocarcinoma by targeting KLF4 and promises a novel diagnostic marker.MicroRNA-145 Modulates N6-Methyladenosine Levels by Targeting the 3'-Untranslated mRNA Region of the N6-Methyladenosine Binding YTH Domain Family 2 Protein.MicroRNA-145 Negatively Regulates Cell Proliferation Through Targeting IRS1 in Isolated Ovarian Granulosa Cells From Patients With Polycystic Ovary Syndrome.MicroRNA-216b reduces growth, migration and invasion of pancreatic ductal adenocarcinoma cells by directly targeting ρ-associated coiled-coil containing protein kinase 1.Screening therapeutic targets of ribavirin in hepatocellular carcinoma.Long non-coding RNA linc-ITGB1 promotes cell proliferation, migration and invasion in human hepatoma carcinoma by upregulating ROCK1Updates on the hepatocyte growth factor/c-Met axis in hepatocellular carcinoma and its therapeutic implications
P2860
Q37093868-58CAC90A-D303-4BA8-B2E2-3F9D2CE95CCEQ37596666-B93B0E70-2ABE-48B8-91CA-2366ADED2AA1Q37628264-5E00E770-1C1C-4E06-93D2-BB40FADD613FQ38637994-B0D0FBB7-E572-4622-B018-0DE9C0206AF3Q43907188-C2DA6868-5473-49C7-A08F-4DE82E8BC754Q47654355-768C8D9F-09B9-4746-B176-72F61505BB4CQ48235043-979BD9A5-CA98-4B7F-929A-BC4C92D562F0Q49681001-F04EABFD-F221-45E6-AF38-DC83136ADAC6Q51180526-ED6FCE22-68DC-4F26-8195-CCCA84D41290Q51352256-CB52943A-4C3B-4732-BD5C-29AACE759AE3Q52608454-2458F5AC-E3C5-4F0B-AF6C-464036CF519FQ55331757-3046FA86-29B9-40FA-AF0A-0238A66B378CQ57044000-4ADA62F1-79F5-4BC4-8553-0EF1AADA4AA7Q58760425-EEC12513-447F-4FAB-824F-863C9F88E9C7
P2860
MiR-145 suppresses cell proliferation and motility by inhibiting ROCK1 in hepatocellular carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
MiR-145 suppresses cell prolif ...... 1 in hepatocellular carcinoma.
@en
MiR-145 suppresses cell prolif ...... 1 in hepatocellular carcinoma.
@nl
type
label
MiR-145 suppresses cell prolif ...... 1 in hepatocellular carcinoma.
@en
MiR-145 suppresses cell prolif ...... 1 in hepatocellular carcinoma.
@nl
prefLabel
MiR-145 suppresses cell prolif ...... 1 in hepatocellular carcinoma.
@en
MiR-145 suppresses cell prolif ...... 1 in hepatocellular carcinoma.
@nl
P2093
P2860
P1433
P1476
MiR-145 suppresses cell prolif ...... 1 in hepatocellular carcinoma.
@en
P2093
Changli Jiang
Hongbo Tan
Zhiqiang Li
P2860
P2888
P304
P356
10.1007/S13277-015-4462-3
P577
2015-11-28T00:00:00Z